{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:43:38Z","timestamp":1782837818813,"version":"3.54.5"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.colsurfb.2024.114014","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:41:43Z","timestamp":1717584103000},"page":"114014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy"],"prefix":"10.1016","volume":"241","author":[{"given":"Shiqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-3535","authenticated-orcid":false,"given":"Faisal","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2024.114014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103565","article-title":"Emerging role of exosomes as biomarkers in cancer treatment and diagnosis","volume":"169","author":"Hanjani","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"13","key":"10.1016\/j.colsurfb.2024.114014_bib2","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1039\/D2RA07863E","article-title":"Cancer nanomedicine: a review of nano-therapeutics and challenges ahead","volume":"13","author":"Nirmala","year":"2023","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7555\/JBR.31.20160059","article-title":"Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers","volume":"31","author":"Akhtar","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.colsurfb.2024.114014_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000441-187801000-00004","article-title":"Action of iron, cod-liver oil, and arsenic on the globular richness of the blood","volume":"75","author":"Cutler","year":"1878","journal-title":"Am. J. Med. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.colsurfb.2024.114014_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","article-title":"History of the development of arsenic derivatives in cancer therapy","volume":"6","author":"Waxman","year":"2001","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/1573413716999201207142810","article-title":"Arsenic Trioxide-based nanomedicines as a therapeutic combination approach for treating gliomas: a review","volume":"17","author":"Siddique","year":"2021","journal-title":"Curr. Nanosci."},{"issue":"9","key":"10.1016\/j.colsurfb.2024.114014_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12094-019-02054-6","article-title":"A candidate for lung cancer treatment: arsenic trioxide","volume":"21","author":"Huang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040743","article-title":"Current advances of nanomedicines delivering arsenic trioxide for enhanced tumor therapy","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"47","key":"10.1016\/j.colsurfb.2024.114014_bib9","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1038\/sj.onc.1208868","article-title":"Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway","volume":"24","author":"Scholz","year":"2005","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.colsurfb.2024.114014_bib10","doi-asserted-by":"crossref","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.028","article-title":"Arsenic trioxide up-regulates Fas expression in human osteosarcoma cells","volume":"123","author":"Yang","year":"2010","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib11","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3892\/or.2017.5627","article-title":"Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi\u20111 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP","volume":"37","author":"Kong","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib12","first-page":"3341","article-title":"Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22942","article-title":"Imbalanced GSH\/ROS and sequential cell death","volume":"36","author":"Liu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib14","article-title":"Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date","author":"Yan","year":"2023","journal-title":"Arch. Pharm.\u00a0Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10408360500523878","article-title":"Glutathione in cancer biology and therapy","volume":"43","author":"Estrela","year":"2006","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.colsurfb.2024.114014_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110177","article-title":"Combination treatment with cyclosporin A and arsenic trioxide induce synergistic cell death via non-apoptotic pathway in uterine cervical cancer cells","volume":"368","author":"Wu","year":"2022","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.colsurfb.2024.114014_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054708","article-title":"The role of BCL-2 and PD-1\/PD-L1 pathway in pathogenesis of myelodysplastic syndromes","author":"Kuszczak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.apsb.2020.01.016","article-title":"Arsenic trioxide induces regulatory functions of plasmacytoid dendritic cells through interferon-\u03b1 inhibition","volume":"10","author":"Ye","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s11658-018-0074-4","article-title":"Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells","volume":"23","author":"Sun","year":"2018","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3892\/ijo.2016.3831","article-title":"Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS","volume":"50","author":"Song","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172982","article-title":"Long non-coding RNA ROR confers arsenic trioxide resistance to HepG2 cells by inhibiting p53 expression","volume":"872","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114014_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082195","article-title":"Regulation of autophagy via carbohydrate and lipid metabolism in cancer","volume":"15","author":"Alizadeh","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114014_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib24","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/cas.15803","article-title":"Autophagy and cancer: basic mechanisms and inhibitor development","volume":"114","author":"Hama","year":"2023","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib25","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2020.03.013","article-title":"The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis","volume":"146","author":"Brun","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"15","key":"10.1016\/j.colsurfb.2024.114014_bib26","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1074\/jbc.TM117.000117","article-title":"Ubiquitin signaling and autophagy","volume":"293","author":"Grumati","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2018.01.018","article-title":"Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway","volume":"496","author":"Wu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06749-2","article-title":"Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors","volume":"9","author":"Cui","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2024.114014_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib30","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.3390\/ijms22073765","article-title":"Anti-angiogenic therapy: current challenges and future perspectives","volume":"22","author":"Lopes-Coelho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2024.114014_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biopha.2018.12.022","article-title":"Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases","volume":"110","author":"Fallah","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2024.114014_bib32","article-title":"The research progress of antiangiogenic therapy, immune therapy and tumor microenvironment","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jcm9010084","article-title":"Tumor angiogenesis and anti-angiogenic strategies for cancer treatment","volume":"9","author":"Teleanu","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-022-00838-y","article-title":"Cancer combination therapies by angiogenesis inhibitors; a comprehensive review","volume":"20","author":"Ansari","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10565-018-09458-0","article-title":"Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells","volume":"35","author":"Jiang","year":"2019","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2019.08.009","article-title":"Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a","volume":"315","author":"Sun","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib39","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib40","doi-asserted-by":"crossref","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","article-title":"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.colsurfb.2024.114014_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108665","article-title":"Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine\/docetaxel on neuroblastoma SK-N-SH cells","volume":"113","author":"Qi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"16","key":"10.1016\/j.colsurfb.2024.114014_bib42","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/1871520623666230530095435","article-title":"MDM2-mediated Inhibitory effect of arsenic trioxide on small cell lung cancer cell line by degrading mutant p53","volume":"23","author":"Wang","year":"2023","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cancers11060862","article-title":"Cancer stem cells and radioresistance: DNA repair and beyond","volume":"11","author":"Schulz","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib44","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.18632\/oncotarget.6644","article-title":"Cell cycle-dependent resolution of DNA double-strand breaks","volume":"7","author":"Ambrosio","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2024.114014_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","article-title":"Cancer stem cells: the root of tumor recurrence and metastases","volume":"44","author":"Peitzsch","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","article-title":"Cancer stem cells in osteosarcoma","volume":"386","author":"Brown","year":"2017","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.21037\/tlcr-20-467","article-title":"Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell- maintenance factors and inducing apoptosis via the Hedgehog signaling blockade","volume":"9","author":"Chang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.335","article-title":"Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF\/JAK1\/STAT3 and NF-kB signaling pathways synergistically","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib49","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","article-title":"Emerging mechanisms and targeted therapy of ferroptosis in cancer","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.colsurfb.2024.114014_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107992","article-title":"Emerging role of ferroptosis in breast cancer: new dawn for overcoming tumor progression","volume":"232","author":"Sui","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2024.114014_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"21","key":"10.1016\/j.colsurfb.2024.114014_bib54","article-title":"Nano ultrasound contrast agent for synergistic chemo-photothermal therapy and enhanced immunotherapy against liver cancer and metastasis","volume":"10","author":"Qiu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114014_bib55","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1039\/D0MH01992E","article-title":"PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization","volume":"8","author":"Wang","year":"2021","journal-title":"Mater. Horiz."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308894","article-title":"Designing hydrogels for immunomodulation in cancer therapy and regenerative medicine","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2024.114014_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2016.12.001","article-title":"Arsenic trioxide is an immune adjuvant in liver cancer treatment","volume":"81","author":"Wang","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109899","article-title":"Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma","volume":"117","author":"Yin","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.colsurfb.2024.114014_bib59","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3324\/haematol.2018.198614","article-title":"Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group","volume":"103","author":"Ad\u00e8s","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1039\/c9mt00308h","article-title":"Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases","volume":"12","author":"Wang","year":"2020","journal-title":"Metallomics"},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020382118","article-title":"Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)","volume":"118","author":"Chen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.colsurfb.2024.114014_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41408-022-00753-y","article-title":"An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)","volume":"12","author":"Wang","year":"2022","journal-title":"Blood Cancer J."},{"issue":"17","key":"10.1016\/j.colsurfb.2024.114014_bib63","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/cncr.29456","article-title":"Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma","volume":"121","author":"Wang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.colsurfb.2024.114014_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1001829","article-title":"Phase I\/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma","volume":"13","author":"Han","year":"2022","journal-title":"Front. Neurol."},{"issue":"7-8","key":"10.1016\/j.colsurfb.2024.114014_bib65","first-page":"791","article-title":"Excellent early outcomes of combined chemotherapy with arsenic trioxide for stage 4\/M neuroblastoma in children: a multicenter nonrandomized controlled trial","volume":"28","author":"Li","year":"2020","journal-title":"Oncol. Res."},{"issue":"13","key":"10.1016\/j.colsurfb.2024.114014_bib66","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","article-title":"Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial","volume":"16","author":"Burnett","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","article-title":"Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the children's oncology group AAML1331 trial","volume":"8","author":"Kutny","year":"2022","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib68","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00277-020-04010-9","article-title":"Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death","volume":"99","author":"Min","year":"2020","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/med.21844","article-title":"Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors","volume":"42","author":"S\u00f6nksen","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1389557519666191018155426","article-title":"Will arsenic trioxide benefit treatment of solid tumor by nano- encapsulation?","volume":"20","author":"Fu","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1208\/s12249-022-02254-4","article-title":"Albumin-embellished arsenic trioxide-loaded polymeric nanoparticles enhance tumor accumulation and anticancer efficacy via transcytosis for hepatocellular carcinoma therapy","volume":"23","author":"Huang","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2024.114014_bib72","doi-asserted-by":"crossref","DOI":"10.1021\/acsanm.3c04487","article-title":"Advantages of nanomedicine in cancer therapy: a review","author":"Wang","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/acs.nanolett.0c04638","article-title":"Keeping nanomedicine on target","volume":"21","author":"Zhang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.colsurfb.2024.114014_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib75","article-title":"Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles","volume":"34","author":"Alavi","year":"2019","journal-title":"Drug Metab. Pers. Ther."},{"key":"10.1016\/j.colsurfb.2024.114014_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2024.114014_bib77","article-title":"Liposomes for tumor targeted therapy: a review","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4068\/cmj.2021.57.1.27","article-title":"Liposomes: biomedical applications","volume":"57","author":"Kim","year":"2021","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.colsurfb.2024.114014_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119385","article-title":"Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: a mini review","volume":"583","author":"Fei","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114014_bib80","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.2147\/IJN.S313962","article-title":"Liposome-coated arsenic-manganese complex for magnetic resonance imaging-guided synergistic therapy against carcinoma","volume":"16","author":"Jin","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2024.114014_bib81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.11.042","article-title":"Folate-targeted liposomal nitrooxy-doxorubicin: an effective tool against P-glycoprotein-positive and folate receptor-positive tumors","volume":"270","author":"Gazzano","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114014_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121209","article-title":"MMP2-responsive dual-targeting drug delivery system for valence-controlled arsenic trioxide prodrug delivery against hepatic carcinoma","volume":"609","author":"Li","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114014_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib84","article-title":"Polymer-based drug delivery systems for anticancer drugs: a systematic review","volume":"32","author":"Salari","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.colsurfb.2024.114014_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","article-title":"PEG\u2013PLGA copolymers: their structure and structure-influenced drug delivery applications","volume":"183","author":"Zhang","year":"2014","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib86","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425247.2023.2223941","article-title":"Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy","volume":"20","author":"Narmani","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2024.114014_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122587","article-title":"RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy","volume":"633","author":"Yadav","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114014_bib88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semcancer.2022.06.003","article-title":"Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy","volume":"86","author":"Dey","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118814","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114014_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119489","article-title":"Chitosan nanocarriers for microRNA delivery and detection: a preliminary review with emphasis on cancer","volume":"290","author":"Sargazi","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020473","article-title":"Chitosan nanoparticle-based system: a new insight into the promising controlled release system for lung cancer treatment","volume":"27","author":"Yee Kuen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2024.114014_bib92","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.colsurfb.2019.04.036","article-title":"Surface-modified PLGA nanoparticles with PEG\/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced","volume":"180","author":"Song","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib93","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.apsb.2021.06.012","article-title":"The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2024.114014_bib94","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.2147\/IJN.S175418","article-title":"A novel RGDyC\/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system","volume":"13","author":"Lu","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2024.114014_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/md21040211","article-title":"Chitosan nanoparticles-based cancer drug delivery: application and challenges","author":"Sachdeva","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.colsurfb.2024.114014_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120462","article-title":"Thiolated chitosan nanoparticles for stable delivery and smart release of As2O3 for liver cancer through dual actions","volume":"303","author":"Song","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"35","key":"10.1016\/j.colsurfb.2024.114014_bib97","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1039\/D1CC00811K","article-title":"Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications","volume":"57","author":"Wang","year":"2021","journal-title":"Chem. Commun."},{"issue":"11","key":"10.1016\/j.colsurfb.2024.114014_bib98","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1039\/C6NR00536E","article-title":"Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study","volume":"8","author":"Chen","year":"2016","journal-title":"Nanoscale"},{"issue":"37","key":"10.1016\/j.colsurfb.2024.114014_bib99","doi-asserted-by":"crossref","first-page":"8684","DOI":"10.1039\/D0TB01295E","article-title":"Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE)","volume":"8","author":"Zhao","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13036-022-00298-5","article-title":"Dendrimer-based drug delivery systems: history, challenges, and latest developments","volume":"16","author":"Wang","year":"2022","journal-title":"J. Biol. Eng."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib101","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.colsurfb.2024.114014_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2019.11.012","article-title":"Emergence in protein derived nanomedicine as anticancer therapeutics: more than a tour de force","volume":"69","author":"Wang","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114014_bib104","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.colsurfb.2017.06.039","article-title":"Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers","volume":"158","author":"Kim","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib105","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/C5CS00158G","article-title":"Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy","volume":"45","author":"Liu","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.colsurfb.2024.114014_bib106","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jconrel.2022.08.054","article-title":"Self-activated arsenic manganite nanohybrids for visible and synergistic thermo\/immuno-arsenotherapy","volume":"350","author":"Zhai","year":"2022","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1039\/D1BM01374B","article-title":"Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC","volume":"10","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/07388551.2017.1312267","article-title":"Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems","volume":"38","author":"Malekzad","year":"2018","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jfoodeng.2019.04.020","article-title":"Impact of deamidation on gliadin-based nanoparticle formation and curcumin encapsulation","volume":"260","author":"Wang","year":"2019","journal-title":"J. Food Eng."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2024.114014_bib111","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.msec.2019.01.129","article-title":"Functionalized mesoporous silica nanoparticles and biomedical applications","volume":"99","author":"Hoang Thi","year":"2019","journal-title":"Mater. Sci. Eng. C\u00a0Mater. Biol. Appl."},{"key":"10.1016\/j.colsurfb.2024.114014_bib112","article-title":"Applications and biocompatibility of mesoporous silica nanocarriers in the field of medicine","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.apsb.2018.01.007","article-title":"Mesoporous silica nanoparticles for drug and gene delivery","volume":"8","author":"Zhou","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2024.114014_bib114","article-title":"Brief history, preparation method, and biological application of mesoporous silica molecular sieves: a narrative review","author":"Li","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114014_bib115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/acs.molpharmaceut.8b01056","article-title":"Angiopep-2-conjugated \u201cCore\u2013Shell\u201d hybrid nanovehicles for targeted and pH-triggered delivery of arsenic trioxide into glioma","volume":"16","author":"Tao","year":"2019","journal-title":"Mol. Pharm."},{"issue":"15","key":"10.1016\/j.colsurfb.2024.114014_bib116","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1039\/D3BM00555K","article-title":"PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy","volume":"11","author":"Jiang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.colsurfb.2024.114014_bib117","doi-asserted-by":"crossref","first-page":"1039154","DOI":"10.3389\/fbioe.2022.1039154","article-title":"Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy","volume":"10","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib118","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.actbio.2018.07.007","article-title":"Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy","volume":"76","author":"Lin","year":"2018","journal-title":"Acta Biomater."},{"issue":"1-2","key":"10.1016\/j.colsurfb.2024.114014_bib119","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2017.01.031","article-title":"RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma","volume":"519","author":"Fei","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib120","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/tcr.202000104","article-title":"Silica-based nanoparticles as drug delivery vehicles for prostate cancer treatment","volume":"21","author":"Tiburcius","year":"2021","journal-title":"Chem. Rec."},{"key":"10.1016\/j.colsurfb.2024.114014_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/nano7070189","article-title":"Mesoporous silica nanoparticles as drug delivery vehicles in cancer","author":"Watermann","year":"2017","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib122","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10408398.2018.1536966","article-title":"Multifunctional nanocellulose\/metal and metal oxide nanoparticle hybrid nanomaterials","volume":"60","author":"Oun","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib123","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1039\/D2RA07936D","article-title":"A review on the synthesis of metal oxide nanomaterials by microwave induced solution combustion","volume":"13","author":"Yin","year":"2023","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib124","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1021\/acsami.9b22802","article-title":"Delivery of arsenic trioxide by multifunction nanoparticles to improve the treatment of hepatocellular carcinoma","volume":"12","author":"Wu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2024.114014_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688927","article-title":"Iron oxide nanoparticles in bioimaging - an immune perspective","volume":"12","author":"Geppert","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib126","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1021\/acsami.2c14962","article-title":"Arsenic-loaded biomimetic iron oxide nanoparticles for enhanced ferroptosis-inducing therapy of hepatocellular carcinoma","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib127","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17425247.2019.1554647","article-title":"Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics","volume":"16","author":"Vangijzegem","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2024.114014_bib128","article-title":"Metal-based nano-delivery platform for treating bone disease and regeneration","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.colsurfb.2024.114014_bib129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhazmat.2016.01.066","article-title":"Where does the toxicity of metal oxide nanoparticles come from: the nanoparticles, the ions, or a combination of both?","volume":"308","author":"Wang","year":"2016","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.colsurfb.2024.114014_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121322","article-title":"Recent development of metal-organic framework nanocomposites for biomedical applications","volume":"281","author":"Ge","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7150\/thno.80687","article-title":"Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.colsurfb.2024.114014_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201906846","article-title":"Metal-organic frameworks for biomedical applications","volume":"16","author":"Yang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2024.114014_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/catal9010052","article-title":"A review on the synthesis and characterization of metal organic frameworks for photocatalytic water purification","author":"Bedia","year":"2019","journal-title":"Catalysts"},{"key":"10.1016\/j.colsurfb.2024.114014_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114496","article-title":"Nanoscale MOFs: from synthesis to drug delivery and theranostics applications","volume":"190","author":"Ding","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"57","key":"10.1016\/j.colsurfb.2024.114014_bib135","doi-asserted-by":"crossref","first-page":"13189","DOI":"10.1002\/chem.201902599","article-title":"Zeolitic imidazolate framework-8 as pH-sensitive nanocarrier for \"Arsenic Trioxide\u201d\u00a0drug delivery","volume":"25","author":"Ettlinger","year":"2019","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib136","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12951-021-01161-3","article-title":"Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"12","key":"10.1016\/j.colsurfb.2024.114014_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.202000185","article-title":"In vitro studies of Fe3O4-ZIF-8 core-shell nanoparticles designed as potential theragnostics","volume":"37","author":"Ettlinger","year":"2020","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.colsurfb.2024.114014_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213975","article-title":"Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents","volume":"441","author":"Gou","year":"2021","journal-title":"Coord. Chem. Rev."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002081","article-title":"Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy","volume":"10","author":"Raza","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"36","key":"10.1016\/j.colsurfb.2024.114014_bib140","doi-asserted-by":"crossref","first-page":"20068","DOI":"10.1039\/C8RA01417E","article-title":"Preparation and characterization of erythrocyte membrane cloaked PLGA\/arsenic trioxide nanoparticles and evaluation of their in vitro anti-tumor effect","volume":"8","author":"Su","year":"2018","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010021","article-title":"Erythrocyte membrane-coated arsenic trioxide-loaded sodium alginate nanoparticles for tumor therapy","volume":"12","author":"Lian","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2024.114014_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151709","article-title":"SP94 engineered erythrocyte membrane enhanced the targeted delivery of biomimetic nanosuspension with IDO immunotherapy and chemotherapy in liver cancer","author":"Raza","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib143","article-title":"hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype","volume":"15","author":"Su","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213683","article-title":"Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy","volume":"155","author":"Raza","year":"2023","journal-title":"Biomater. Adv."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2024.114014_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/nano12091543","article-title":"Latest advances in biomimetic cell membrane-coated and membrane-derived nanovectors for biomedical applications","author":"Rampado","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.colsurfb.2024.114014_bib147","article-title":"Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications","volume":"24","author":"Ding","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"7","key":"10.1016\/j.colsurfb.2024.114014_bib148","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1021\/acsnano.7b02533","article-title":"Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib149","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.drudis.2018.02.001","article-title":"Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics","volume":"23","author":"Bose","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114014_bib150","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201604300","article-title":"Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer","volume":"27","author":"Sun","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2024.114014_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120467","article-title":"Extracellular vesicles: a bright star of nanomedicine","volume":"269","author":"Wu","year":"2021","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib153","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1039\/D3BM01980B","article-title":"Tumor-derived microvesicles for cancer therapy","volume":"12","author":"Yang","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.colsurfb.2024.114014_bib154","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.semcancer.2019.08.017","article-title":"Extracellular vesicles in cancer nanomedicine","volume":"69","author":"Tarasov","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"26","key":"10.1016\/j.colsurfb.2024.114014_bib155","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.7150\/thno.37097","article-title":"Extracellular vesicle-based drug delivery systems for cancer treatment","volume":"9","author":"Walker","year":"2019","journal-title":"Theranostics"},{"issue":"14","key":"10.1016\/j.colsurfb.2024.114014_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202005709","article-title":"Engineered extracellular vesicles for cancer therapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib157","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.matt.2023.01.012","article-title":"Exosome membrane-coated nanosystems: Exploring biomedical applications in cancer diagnosis and therapy","volume":"6","author":"Shao","year":"2023","journal-title":"Matter"},{"issue":"13","key":"10.1016\/j.colsurfb.2024.114014_bib158","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.7150\/thno.57828","article-title":"Recent progress in nanomedicine for enhanced cancer chemotherapy","volume":"11","author":"Wei","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2024.114014_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648407","article-title":"Clinically-relevant ABC transporter for anti-cancer drug resistance","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharm."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial","volume":"35","author":"Platzbecker","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib161","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/jcmm.13436","article-title":"Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"24","key":"10.1016\/j.colsurfb.2024.114014_bib162","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.7150\/thno.49425","article-title":"Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.colsurfb.2024.114014_bib163","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2217\/fon-2016-0010","article-title":"Pancreatic cancer: yesterday, today and tomorrow","volume":"12","author":"Ansari","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.colsurfb.2024.114014_bib164","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trsl.2022.11.007","article-title":"Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1\/PI3K\/AKT\/mTOR axis","volume":"255","author":"Tian","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.colsurfb.2024.114014_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2019.119030","article-title":"Beyond cisplatin: combination therapy with arsenic trioxide","volume":"496","author":"Miodragovi\u0107","year":"2019","journal-title":"Inorg. Chim. Acta"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib166","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1756-9966-28-110","article-title":"Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction","volume":"28","author":"Li","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"49","key":"10.1016\/j.colsurfb.2024.114014_bib167","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1002\/anie.200903655","article-title":"Coencapsulation of arsenic- and platinum-based drugs for targeted cancer treatment","volume":"48","author":"Chen","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib168","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1039\/C8BM01039K","article-title":"Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy","volume":"7","author":"Xin","year":"2019","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114014_bib169","first-page":"3404","article-title":"Synergistic effect of arsenic trioxide, vismodegib and temozolomide on glioblastoma","volume":"41","author":"Bureta","year":"2019","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114014_bib170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11060-017-2469-x","article-title":"A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas","volume":"133","author":"Kumthekar","year":"2017","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib171","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41401-021-00648-x","article-title":"Lipid\/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide\/paclitaxel against breast cancer cells","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.colsurfb.2024.114014_bib172","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/08880018.2021.1872748","article-title":"Arsenic trioxide in pediatric cancer - a case series and review of literature","volume":"38","author":"Abele","year":"2021","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114014_bib173","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2174723","article-title":"Arsenic trioxide as an inducer of immunogenic cell death","volume":"12","author":"Kepp","year":"2023","journal-title":"OncoImmunology"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652400273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652400273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:14:34Z","timestamp":1722042874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652400273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":173,"alternative-id":["S092777652400273X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114014","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114014"}}